These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26680217)

  • 1. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
    Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
    BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
    Raine R; Duffy SW; Wardle J; Solmi F; Morris S; Howe R; Kralj-Hans I; Snowball J; Counsell N; Moss S; Hackshaw A; von Wagner C; Vart G; McGregor LM; Smith SG; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Atkin W
    Br J Cancer; 2016 Feb; 114(3):321-6. PubMed ID: 26742011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.
    Raine R; Moss SM; von Wagner C; Atkin W; Hans IK; Howe R; Solmi F; Morris S; Counsell N; Hackshaw A; Halloran S; Handley G; Logan RF; Rainbow S; Smith S; Snowball J; Seaman H; Thomas M; Smith SG; McGregor LM; Vart G; Wardle J; Duffy SW
    Br J Cancer; 2016 Dec; 115(12):1479-1486. PubMed ID: 27875518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decomposing socio-economic inequality in colorectal cancer screening uptake in England.
    Solmi F; Von Wagner C; Kobayashi LC; Raine R; Wardle J; Morris S
    Soc Sci Med; 2015 Jun; 134():76-86. PubMed ID: 25917138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial.
    Cross AJ; Myles J; Greliak P; Hackshaw A; Halloran S; Benton SC; Addison C; Chapman C; Djedovic N; Smith S; Wagner CV; Duffy SW; Raine R
    J Med Screen; 2021 Dec; 28(4):419-425. PubMed ID: 33645308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
    McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
    BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.
    McGregor LM; von Wagner C; Atkin W; Kralj-Hans I; Halloran SP; Handley G; Logan RF; Rainbow S; Smith S; Snowball J; Thomas MC; Smith SG; Vart G; Howe R; Counsell N; Hackshaw A; Morris S; Duffy SW; Raine R; Wardle J
    Gastroenterol Res Pract; 2016; 2016():3670150. PubMed ID: 27069473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive ability and personality as predictors of participation in a national colorectal cancer screening programme: the English Longitudinal Study of Ageing.
    Gale CR; Deary IJ; Wardle J; Zaninotto P; Batty GD
    J Epidemiol Community Health; 2015 Jun; 69(6):530-5. PubMed ID: 25648994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation.
    Quyn AJ; Fraser CG; Stanners G; Carey FA; Carden C; Shaukat A; Steele RJ
    J Med Screen; 2018 Mar; 25(1):24-31. PubMed ID: 29183246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
    Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving uptake of flexible sigmoidoscopy screening: a randomized trial of nonparticipant reminders in the English Screening Programme.
    Kerrison RS; McGregor LM; Marshall S; Isitt J; Counsell N; Rees CJ; von Wagner C
    Endoscopy; 2017 Jan; 49(1):35-43. PubMed ID: 27997965
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of an enhanced invitation letter on uptake of National Health Service Health Checks in primary care: a pragmatic quasi-randomised controlled trial.
    Sallis A; Bunten A; Bonus A; James A; Chadborn T; Berry D
    BMC Fam Pract; 2016 Mar; 17():35. PubMed ID: 27009045
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.